<DOC>
	<DOCNO>NCT00976287</DOCNO>
	<brief_summary>The purpose study investigate efficacy autologous bone marrow mesenchymal stem cell ( MSCs ) transplantation via hepatic artery treatment liver cirrhosis . Liver function monitor serum examination . The level serum alanine aminotransferase ( ALT ) , total bilirubin ( TB ) , prothrombin time ( PT ) albumin ( ALB ) examine pre-transplantation , 3 day 2 year post-transplantation . Child-Pugh score clinical symptom also observe simultaneously .</brief_summary>
	<brief_title>Autologous Bone Marrow Mesenchymal Stem Cells Transplantation Via Hepatic Artery Patients With Liver Cirrhosis</brief_title>
	<detailed_description>Patients liver cirrhosis randomly separate two group . Autologous MSCs infuse patient use interventional method via hepatic artery One group . The catheter insert proper hepatic artery . After catheter place proper hepatic artery confirm angiography , autologous bone marrow MSCs infuse slowly 20-30 minute . The control group accept conserved therapy .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>Age 1870 year . Imaging evidence liver cirrhosis . ChildPlough score 10 . Liver tumor ultrasonography , CT MRI examination . Problems organs liver ( e.g.the heart lung ) . History moderate severe hepatic encephalopathy variceal bleeding . Imaging evidence vascular thromboses . Coma .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Stem cell</keyword>
	<keyword>Liver cirrhosis</keyword>
	<keyword>Radiology</keyword>
	<keyword>Interventional</keyword>
	<keyword>Transplantation</keyword>
</DOC>